Genetic aspects of primary hyperoxaluria: diagnostics and treatment


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Primary hyperoxaluria is a group of inherited metabolic diseases characterized by increased formation of calcium-oxalate stones in kidneys with development of nephrolithiasis and chronic kidney disease. The article summarizes the modern information on the diagnostics and treatment of the disorder depending on genotype of the patient (AGXT, GRHPR, HOGA1 genes). The evaluation of the molecular genetic aetiology of the kidney stone disease contributes to the personalized treatment and prevention of the pathology in the patients and their relatives.

Full Text

Restricted Access

About the authors

T. V Filippova

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: dr.filippova@mail.ru

D. V Svetlichnaya

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University); Moscow Regional Research and Clinical Institute

Email: div.swet@gmail.com

V. I Rudenko

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: rudenko-vadim@rambler.ru

Y. G Alyaev

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: ugalyaev@mail.ru

M. V Shumikhina

N.F. Filatov Children’s City Hospital of Moscow Healthcare Ministry

Email: marina.shumikhina@gmail.com

M. M Azova

Peoples’ Friendship University of Russia

Email: azovam@mail.ru

T. I Subbotina

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: subbotina@1msmu.ru

Z. K Gadzhieva

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: zgadzhieva@ooorou.ru

A. Yu Asanov

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: aliy@rambler.ru

M. M Litvinova

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University); The Loginov Moscow Clinical Scientific Center of Moscow Health Department

Email: ariya.litvinova@gmail.com

References

  1. Kurt-Sukur E.D., Ozgakar Z.B., Fitoz S., Yilmaz S., Hoppe B., Yalginkaya F. Primary Hyperoxaluria Type 1: A Cause for Infantile Renal Failure and Massive Nephrocalcinosis. Klin. Padiatr. 2015; 227(5): 293-295.
  2. Campfield T., Braden G., Flynnvalone P., Powell S. Effect of diuretics on urinary oxalate, calcium, and sodium excretion in very low birth weight infants. Pediatrics 1997;99(6):814-818.
  3. Чугунова О.Л., Шумихина М.В., Павлушкина Л.В. Основные факторы риска развития мочекаменной болезни у детей. Педиатрия. 2018;97(5):93-103
  4. Ben-Shalom E., Frishberg Y. Primary hyperoxalurias: diagnosis and treatment. Pediatr. Nephrol. 2015;30(10):1781-1791.
  5. Lorenzo V., Torres A., Salido E. Hiperoxaluria primaria. Nefrologia 2014;34(3):398-412.
  6. Sas D.J., Harris P.C., Milliner D.S. Recent advances in the identification and management of inherited hyperoxalurias. Urolithiasis. 2019;47(1): 79-89.
  7. Greed L., Willis F., Johnstone L. et al. Metabolite diagnosis of primary hyperoxaluria type 3. Pediatr. Nephrol. 2018;33(8):1443-1446.
  8. Primary hyperoxaluria mutation database [Электронный ресурс]. Режим доступа: http://www.uclh.nhs.uk/OurServices/ServiceA-Z/ PATH/PATHBIOMED/CBIO/Pages/Phmdatabase.aspx (02.06.2019).
  9. Canales B.K., Hatch M. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria. Surg. Obes. Relat. Dis. 2017;13(7):1152-1157.
  10. Aryans D., Jung Y.-C., Antonopoulos D. et al. Oxalobacter formigenes - Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells. J. Am. Soc. Nephrol. 2017;28(3):876-887.
  11. Milliner D., Hoppe B., Groothoff J. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Urolithiasis. 2018;46(4): 313-323.
  12. Hulton S.A. The primary hyperoxalurias: A practical approach to diagnosis and treatment. Int. J. Surg. 2016;36(PD):649-654.
  13. Büscher R., Büscher A.K., Cetiner M. et al. Combined liver and kidney transplantation and kidney after liver transplantation in children: Indication, postoperative outcome, and long-term results. Pediatr. Transplant. 2015;19(8):858-865

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies